Novartis to buy US-listed Avidity Biosciences for $12 bln
Welcome to Thepointnews – your trusted source for timely, reliable, and insightful news. At Thepointnews, we believe in delivering accurate information, balanced perspectives, and meaningful stories that matter to our readers. In a world overflowing with headlines, our mission is simple: to cut through the noise and bring you news that is clear, factual, and relevant.
© Copyright -The point news-2025